| Literature DB >> 36204713 |
Vânia Maphossa1, José Carlos Langa2, Samuel Simbine2, Fabião Edmundo Maússe2, Darlene Kenga2, Ventura Relvas2, Valéria Chicamba3, Alice Manjate2, Jahit Sacarlal2.
Abstract
Background: The hospital environment serves as a reservoir of microorganisms which may be associated with healthcare-associated infections (HCAI). The study of environmental contamination with microorganisms is a method for the assessment of hospital environmental hygiene. We sought to evaluate the environmental colonisation of a national reference hospital unit, using the total aerobic colony count (ACC) and the isolated microorganisms, as assessment tools.Entities:
Keywords: Contamination; Environment; Healthcare-associated infections; Surfaces
Year: 2022 PMID: 36204713 PMCID: PMC9530480 DOI: 10.1016/j.infpip.2022.100250
Source DB: PubMed Journal: Infect Prev Pract ISSN: 2590-0889
Figure 1Surfaces median total ACC, before and after room cleaning.
Isolated microorganisms and distribution among the air indoor and surfaces
| Sampling site | Isolated microorganisms |
|---|---|
| CoNS (2) | |
| CoNS (5) | |
| CoNS (7) | |
| CoNS (2) | |
| CoNS (3) | |
| CoNS |
The numbers in brackets correspond to number of species isolates on the sampling site.
CoNS- coagulase negative staphylococci.
Frequency of resistance to antibiotics by genus of epidemiological importance
| Antibiotic | CoNS (n=52) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| Ampicillin | 8 | 67 | 5 | 83 | - | - | 6 | 100 | 3 | 100 |
| Ceftriaxone | 4 | 33 | 6 | 100 | - | - | 2 | 33 | - | - |
| Ciprofloxacin | 1 | 8 | 4 | 67 | 5 | 10 | - | - | - | - |
| Chloramphenicol | 6 | 50 | 3 | 50 | 17 | 33 | - | - | - | - |
| Trimethoprim-sulfamethoxazole | 6 | 50 | 5 | 83 | 27 | 52 | 1 | 17 | 2 | 67 |
| Erythromycin | - | - | - | - | 33 | 63 | - | - | - | - |
| Gentamicin | 4 | 33 | 5 | 83 | 18 | 35 | - | - | - | - |
| Penicillin | - | - | - | - | 42 | 81 | - | - | - | - |
| Tetracycline | 1 | 8 | 1 | 17 | 26 | 50 | 1 | 17 | 2 | 67 |
| Nalidixic Acid | 3 | 25 | 6 | 100 | - | - | - | - | - | - |
| Oxacillin | - | - | - | - | 34 | 65 | - | - | - | - |
| Ceftazidime | 6 | 50 | 2 | 33 | - | - | - | - | - | - |
Pattern of antibiotic resistance of MDR bacteria
| Bacteria | Antibiotic resistance pattern | N of MDR (n=63) | N of non-susceptible antibiotic categories |
|---|---|---|---|
| CoNS | C; STX; ER; CN; PE; TE; Ox | 12 | 6 |
| CIP; STX; ER; CN; PE; TE; Ox | 1 | 6 | |
| STX; ER; CN; PE; TE; Ox | 2 | 5 | |
| CIP; STX; CN; PE; TE; Ox | 1 | 5 | |
| CIP; STX; ER; CN; PE; Ox | 1 | 5 | |
| CIP; ER; CN; PE; Ox | 1 | 4 | |
| STX; CN; PE; TE; Ox | 1 | 4 | |
| STX; PE; TE; Ox | 2 | 3 | |
| STX; ER; PE; TE | 2 | 4 | |
| ER; PE; TE; Ox | 1 | 3 | |
| CIP; STX; ER; PE | 1 | 4 | |
| ER; PE; TE | 1 | 3 | |
| AMP; CRO; CIP; C; STX; CN; TE; NA | 1 | 7 | |
| AMP; CRO; CIP; C; STX; CN; NA | 1 | 5 | |
| AMP; CRO; C; STX; NA | 1 | 5 | |
| AMP; CZN; STX | 1 | 3 | |
| AMP; CRO; C; STX; CN; CAZ | 2 | 5 | |
| AMP; CRO; CIP; C; STX; CN; TE; NA; CAZ | 1 | 7 | |
| AMP; CRO; CIP; C; STX; CN; NA | 3 | 5 | |
| AMP; CRO; CIP; NA; CAZ | 1 | 3 | |
| AMP; NA; CN; STX; C; CIP; CRO | 1 | 6 | |
| AMP; CRO; STX; TE | 1 | 4 | |
| AMP; CRO; NA | 2 | 3 | |
| AMP; STX; TE | 2 | 3 | |
| AMP; STX; TE | 1 | 3 | |
| AMP; C; STX; NA | 1 | 4 |
Antibiotic: AMP- Ampicillin; CRO- Ceftriaxone; CIP- Ciprofloxacin; C- Chloramphenicol; SXT- Trimethoprim-sulfamethoxazole; E- Erythromycin; CN- Gentamicin; P- Penicillin; TE-Tetracycline; NA- Nalidicic Acid; OX- Oxacillin; CAZ- Ceftazidime.
CoNS- Coagulase-negative staphylococci.